35
Views
3
CrossRef citations to date
0
Altmetric
Review

Abciximab: a reappraisal of its use in coronary care

, , , , , & show all
Pages 29-39 | Published online: 07 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sascha Meyer dos Santos, Karina Kuczka, Bettina Picard-Willems, Karen Nelson, Ute Klinkhardt & Sebastian Harder. (2015) The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow. Platelets 26:1, pages 59-66.
Read now

Articles from other publishers (2)

Yan Zhang, Jianliang Wang, Zhaoxi Ma, Guihua Mu, Da Liang, Yifan Li, Xiaoyan Qian, Luyuan Zhang, Fang Shen, Lei Zhang, Jie Yu & Yang Liu. (2022) Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis. Frontiers in Neurology 13.
Crossref
Danique L. van den Kerkhof, Paola E.J. van der Meijden, Tilman M. Hackeng & Ingrid Dijkgraaf. (2021) Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past, Present and Future Applications. International Journal of Molecular Sciences 22:7, pages 3366.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.